NEW YORK--Pfizer Inc. today issued the following statement regarding a pending court case in Utah:
"The parties to Brigham Young University and Dr. Daniel Simmons v. Pfizer Inc. et al., a matter in the United States Court for the District of Utah, Central Division, announce that they have reached an amicable settlement on confidential terms. As part of the resolution, BYU will establish the Dan Simmons Chair in recognition of Dr. Simmons' lifelong work and contributions towards advancing human health in a number of important areas including oncology, pain and Alzheimer's.
"We are pleased to resolve this matter and the uncertainty of litigation and to be in a position to support Dr. Simmons' research efforts at BYU."
Contacts
Pfizer Inc.
Media Contact:
Chris Loder, 212-733-7897
or
Investor Contact:
Suzanne Harnett, 212-733-8009